Evaluating Serum Surfactant Protein-D, KL-6, and Deep Learning Approaches on Chest X-rays for Lung Fibrosis Detection: A Prospective Observational Investigation - Scorecard - MDSpire
Advertisement
Evaluating Serum Surfactant Protein-D, KL-6, and Deep Learning Approaches on Chest X-rays for Lung Fibrosis Detection: A Prospective Observational Investigation
Clinical Scorecard: Evaluating Serum Surfactant Protein-D, KL-6, and Deep Learning Approaches on Chest X-rays for Lung Fibrosis Detection: A Prospective Observational Investigation
At a Glance
Category
Detail
Condition
Lung Fibrosis
Key Mechanisms
Detection through serum biomarkers (SP-D, KL-6) and deep learning algorithms for chest radiographs.
Target Population
Individuals aged 50–100 years undergoing routine health checkups.
Care Setting
Health checkup facilities and hospitals in Japan.
Key Highlights
Serum SP-D and KL-6 levels are elevated in pulmonary fibrosis and used for early detection.
Fine crackles are a common early indicator of pulmonary fibrosis.
Deep learning algorithms like BMAX have been developed for detecting fibrosing ILD from chest radiographs.
Chest CT is used for secondary screening after initial health checkup evaluations.
The study emphasizes the importance of early detection and treatment initiation for improved outcomes.
Guideline-Based Recommendations
Diagnosis
Use serum SP-D and KL-6 levels for differentiating ILD patients from healthy individuals.
Chest radiographs should be reviewed for abnormalities warranting further evaluation.
Management
Initiate antifibrotic therapy upon early detection of lung fibrosis.
Monitoring & Follow-up
Regular monitoring of serum SP-D and KL-6 levels in patients with suspected ILD.
Risks
Progression rates of lung fibrosis can range from 20 to 76% if not detected early.
Patient & Prescribing Data
Individuals undergoing routine health checkups, particularly those aged 50–100 years.
Antifibrotic drugs can reduce the annual decline in forced vital capacity by approximately 50%.
Clinical Best Practices
Incorporate serum biomarker testing in routine health checkups for early detection of lung fibrosis.
Utilize deep learning algorithms for improved accuracy in chest radiograph interpretations.
